Cyclacel, which was spun out by Dundee University and led by Professor Sir David Lane, reported strong results from trialling a cancer drug, Sapacitabine, that disrupts DNA and stops cells reproducing.
BBC: Life Sciences laboratory worker
2.
The latest findings indicate that a person aged over 75 with AML may live 9.4 months, while using the drug sapacitabine, whereas those without it live on average for only 3.4 months.